These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6576691)
1. Mechanisms of the synergistic effect of oral dimethyl sulfoxide on antineoplastic therapy. Thuning CA; Fanshaw MS; Warren J Ann N Y Acad Sci; 1983; 411():150-60. PubMed ID: 6576691 [TBL] [Abstract][Full Text] [Related]
2. Potentiation of antineoplastic compounds by oral dimethyl sulfoxide in tumor-bearing rats. Warren J; Sacksteder MR; Jarosz H; Wasserman B; Andreotti PE Ann N Y Acad Sci; 1975 Jan; 243():194-208. PubMed ID: 1055539 [No Abstract] [Full Text] [Related]
3. Regional chemotherapy for bladder neoplasms using continuous intravesical infusion of doxorubicin: impact of concomitant administration of dimethyl sulfoxide on drug absorption and antitumor activity. See WA; Xia Q J Natl Cancer Inst; 1992 Apr; 84(7):510-5. PubMed ID: 1545441 [TBL] [Abstract][Full Text] [Related]
4. Late dimethyl sulfoxide administration provides a protective action against chemically induced injury in both the liver and the kidney. Lind RC; Gandolfi AJ Toxicol Appl Pharmacol; 1997 Jan; 142(1):201-7. PubMed ID: 9007050 [TBL] [Abstract][Full Text] [Related]
5. Synergistic cytotoxicity of combinations of dimethyl sulfoxide and antineoplastic agents against P388 leukemia in CD-F1 mice. Pommier RF; Woltering EA; Milo G; Fletcher WS Anticancer Drugs; 1992 Dec; 3(6):635-9. PubMed ID: 1288734 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of dimethyl sulfoxide and antineoplastic combinations against human tumors. Pommier RF; Woltering EA; Milo G; Fletcher WS Am J Surg; 1988 May; 155(5):672-6. PubMed ID: 3369622 [TBL] [Abstract][Full Text] [Related]
7. Enhancing effect of new biological response modifier sulfoethylated (1-->3)-beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses. Khalikova TA; Korolenko TA; Zhanaeva SY; Kaledin VI; Kogan G Exp Oncol; 2006 Dec; 28(4):308-13. PubMed ID: 17285116 [TBL] [Abstract][Full Text] [Related]
8. Synergistic cytotoxicity between dimethyl sulfoxide and antineoplastic agents against ovarian cancer in vitro. Pommier RF; Woltering EA; Milo G; Fletcher WS Am J Obstet Gynecol; 1988 Oct; 159(4):848-52. PubMed ID: 3177534 [TBL] [Abstract][Full Text] [Related]
9. Hepatoprotection by dimethyl sulfoxide. II. Characterization of optimal dose and the latest time of administration for effective protection against chloroform and bromobenzene induced injury. Lind RC; Gandolfi AJ Exp Toxicol Pathol; 1999 Nov; 51(6):537-43. PubMed ID: 10661812 [TBL] [Abstract][Full Text] [Related]
10. NTP toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344/N rats and B6C3F1 mice and male BALB/c and am3-C57BL/6 mice. Bucher JR Toxic Rep Ser; 2007 Jan; (72):1-G4. PubMed ID: 17342194 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat. Swanson BN; Mojaverian P; Boppana VK J Toxicol Environ Health; 1983; 12(2-3):213-22. PubMed ID: 6655731 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of hyperosmotic agents of dimethyl sulfoxide and glycerol on optical clearing of gastric tissue studied with near infrared spectroscopy. Xu X; Wang RK Phys Med Biol; 2004 Feb; 49(3):457-68. PubMed ID: 15012013 [TBL] [Abstract][Full Text] [Related]
13. Inability of dimethyl sulfoxide to increase brain uptake of water-soluble compounds: implications to chemotherapy for brain tumors. Greig NH; Sweeney DJ; Rapoport SI Cancer Treat Rep; 1985 Mar; 69(3):305-12. PubMed ID: 3978658 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of in vitro chemotherapeutic activity by dimethylsulfoxide. Tofilon PJ; Vines CM; Milas L Clin Exp Metastasis; 1985; 3(2):141-50. PubMed ID: 4042462 [TBL] [Abstract][Full Text] [Related]
15. Dimethyl sulfoxide modulation of diabetes onset in NOD mice. Klandorf H; Chirra AR; DeGruccio A; Girman DJ Diabetes; 1989 Feb; 38(2):194-7. PubMed ID: 2914623 [TBL] [Abstract][Full Text] [Related]
16. Role of gp55 in restoring the sensitivity of Friend murine erythroleukemia cells to erythropoietin by exposure to dimethyl sulfoxide. Lin TS; Ishiguro K; Sartorelli AC Oncol Res; 1998; 10(4):175-84. PubMed ID: 9778688 [TBL] [Abstract][Full Text] [Related]
17. Interactions of dimethyl sulfoxide and nonsteroidal anti-inflammatory agents in passive Heymann's nephritis. Kaplan BS; Milner LS; Lotan D; Mills M; Goodyer PR; Fong JS J Lab Clin Med; 1986 May; 107(5):425-30. PubMed ID: 2939160 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of antidotes for extravasation injury produced by 6-hydroxymethylacylfulvene (MGI 114), a novel cytotoxic antitumor agent, in an intradermal toxicity model in rats. Marshall RF; Arthaud LE; MacDonald JR Cancer Chemother Pharmacol; 2000; 45(5):397-401. PubMed ID: 10803923 [TBL] [Abstract][Full Text] [Related]
19. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. Olver IN; Aisner J; Hament A; Buchanan L; Bishop JF; Kaplan RS J Clin Oncol; 1988 Nov; 6(11):1732-5. PubMed ID: 3183703 [TBL] [Abstract][Full Text] [Related]
20. Hepatoprotection by dimethyl sulfoxide. III. Role of inhibition of the bioactivation and covalent bonding of chloroform. Lind RC; Begay CK; Gandolfi AJ Toxicol Appl Pharmacol; 2000 Jul; 166(2):145-50. PubMed ID: 10896856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]